These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7801059)

  • 41. Sulphasalazine in ankylosing spondylitis.
    Feltelius N; Hällgren R
    Ann Rheum Dis; 1986 May; 45(5):396-9. PubMed ID: 2872857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulfasalazine-Related Hypersensitivity Reactions in Patients With Rheumatic Diseases.
    Cildag S; Senturk T
    J Clin Rheumatol; 2017 Mar; 23(2):77-79. PubMed ID: 28121807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sulphasalazine in rheumatoid arthritis.
    Crisp AJ
    Br J Rheumatol; 1984 Aug; 23(3):232. PubMed ID: 6146376
    [No Abstract]   [Full Text] [Related]  

  • 44. Sulphasalazine and male infertility: reversibility and possible mechanism.
    Toovey S; Hudson E; Hendry WF; Levi AJ
    Gut; 1981 Jun; 22(6):445-51. PubMed ID: 6114897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mode of action of sulfasalazine in chronic inflammatory enterocolonic diseases].
    Delboy H
    Therapie; 1992; 47(2):157-9. PubMed ID: 1357770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Articular manifestations in inflammatory bowel disease patients: a prospective study.
    D'Incà R; Podswiadek M; Ferronato A; Punzi L; Salvagnini M; Sturniolo GC
    Dig Liver Dis; 2009 Aug; 41(8):565-9. PubMed ID: 19278908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment.
    Feltelius N; Hällgren R
    Ann Rheum Dis; 1988 Jan; 47(1):10-4. PubMed ID: 2894204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study.
    Kolios AGA; Hueber AJ; Michetti P; Mrowietz U; Mustak-Blagusz M; Sator PG; Reinshagen M; Wilsmann-Theis D; Gomis-Kleindienst S; Luckey U; Rössler A; Schiefke I
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):234-241. PubMed ID: 29998520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome.
    Baiocco PJ; Korelitz BI
    J Clin Gastroenterol; 1984 Jun; 6(3):211-6. PubMed ID: 6144706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome.
    Mogadam M; Dobbins WO; Korelitz BI; Ahmed SW
    Gastroenterology; 1981 Jan; 80(1):72-6. PubMed ID: 6108894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis.
    Haibel H; Specker C
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S159-63. PubMed ID: 19822065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sulphasalazine and inflammatory bowel disease.
    Chapman P
    N Z Med J; 1987 Apr; 100(822):257. PubMed ID: 2901061
    [No Abstract]   [Full Text] [Related]  

  • 53. Antimycobacterial chemotherapy in inflammatory bowel disease.
    Picciotto A; Gesu GP; Schito GC; Testa R; Varagona G; Celle G
    Biomed Pharmacother; 1989; 43(2):141-3. PubMed ID: 2567614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Should tests for proteinuria be included in the monitoring schedule of sulphasalazine?
    Helliwell PS
    Br J Rheumatol; 1995 Aug; 34(8):790-1. PubMed ID: 7551669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment with infliximab in a patient with ankylosing spondylitis and Crohn's disease.
    Rednic S; Marinescu C; Chira R; Rogojan L; Rednic N
    J Gastrointestin Liver Dis; 2006 Dec; 15(4):379-82. PubMed ID: 17205151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
    Ransford RA; Langman MJ
    Gut; 2002 Oct; 51(4):536-9. PubMed ID: 12235076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pancreatitis in inflammatory bowel diseases.
    Pitchumoni CS; Rubin A; Das K
    J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years.
    Gordon MM; Porter DR; Capell HA
    Ann Rheum Dis; 1999 May; 58(5):288-90. PubMed ID: 10225813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acetylation, sulphasalazine and its effects.
    Astbury C; Taggart AJ
    Br J Rheumatol; 1987 Jun; 26(3):229-30. PubMed ID: 2884010
    [No Abstract]   [Full Text] [Related]  

  • 60. Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease.
    van Hees PA
    Acta Gastroenterol Belg; 1987; 50(5):555-9. PubMed ID: 2902723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.